NEW YORK, NY – November 12, 2026 — HITLAB, a health innovation and technology research organization, today announced a strategic partnership with PulseOwn, a health technology company building a patient-sovereign platform that helps people make sense of their health data and control who uses it. HITLAB will bring its design, research, and validation capabilities to help move PulseOwn from concept to a market-ready product, shaped by the healthcare leaders who would adopt it.

Patients generate more health data than ever, from wearables, labs, apps, and providers, but they rarely control where it goes or who benefits from it. Their records are scattered across clinics, labs, and devices, results often arrive without context, and people facing new or unexplained symptoms have no private place to make sense of them before involving a doctor. Currently, most of the protections around that data are usually in a form of a privacy policies only. PulseOwn is built to change that. System is designed so the patients will bring their data together in one place, gain AI-powered insight into their health grounded in their own records, decide who can access their data through transparent consent, and be compensated when they choose to take part in research. Privacy is built into the platform’s design rather than left to policy. PulseOwn is designed not simply as another health-data repository, but as a patient-controlled layer connecting fragmented health information, AI-driven intelligence, consent management and research participation. It gives individuals control over fragmented health data and turns that data into usable personal health intelligence — while enabling transparent, consent-based participation in the broader healthcare ecosystem.

The timing reflects a broader shift. In the U.S., federal interoperability rules, and in Europe, the European Health Data Space, are expanding patients’ rights to access their data, AI is increasing the value of aggregated health information, and consumers are growing wary of platforms that profit from their data without their consent. For a patient-controlled model to succeed, it must work within clinical workflows, regulatory constraints, and investor expectations. Testing it against those realities is the purpose of this partnership.

“Patients should be owners of their health data, not just sources of it, as this will further contribute to the current trend of patient’s emancipation” said Dr. Stan Kachnowski, Chair of HITLAB. “This isn’t just a design exercise. We’re putting PulseOwn’s model in front of the health system, payer, and industry leaders who would actually adopt it, so what gets built reflects what the market needs.”

“Too many health data platforms are built for institutions first and patients second,” said Mihai Diga, Founder and CEO of PulseOwn. “I have spent my career bringing regulated medical technology and digital health services to market, and I have seen how much value patient data creates and how little of it reaches the patient. With PulseOwn, the patient comes first, both in understanding their own health and in deciding who uses their data. Working with HITLAB gives us the clinical and executive perspective to build this the right way from day one.”

HITLAB’s role: HITLAB will validate PulseOwn’s model with health system, payer, pharma, and health IT leaders, turn the findings into PulseOwn’s investor exposure.